...This plan includes a number of improvements towards healthcare delivery in the Kingdom. ...The country s accession to the WTO resulting in new rules on investment in local companies, which will greatly encourage foreign investment in the sector. Intellectual property improvements, particularly the Trade-Related Aspects of Intellectual Property Rights agreement will improve the position of patented medicines in the Saudi market Potential for generic drug market growth, from a low base, boosted by need for cost- containment and pending patent expirations. OTC drug consumption rising on the back of the partial liberalisation of sales, advertising support and an increase in the number of pharmacies, which are promoting greater customer awareness and OTC demand. Considerable scope for local manufacturing sector growth, especially given government support for diversification within the economy. Involvement in the Gulf Central Committee for Drug Registration and other harmonisation initiatives acting as a catalyst for market development.
...BMI View: The combined value of Saudi Arabia s pharmaceutical and healthcare markets is the largest in the Middle East and Africa region. The Kingdom s National Transformation Program, a key part of Vision ----, reinstates the government s commitment to improving healthcare provision in the country. ...The Kingdom s National Transformation Program, a key part of Vision ----, reinstates the government s commitment to improving healthcare provision in the country. Nonetheless, the rising burden of non-communicable diseases will place greater pressure on the country s health services, while opportunities for multinational pharmaceutical companies will develop in line with this. As such, we expect the private sector to play a pivotal role in healthcare expansion in Saudi Arabia over the long term, principally through private health insurance schemes. ...Nonetheless, the rising burden of non-communicable diseases will place greater pressure on the country s health services, while opportunities for multinational pharmaceutical companies will develop in line with this. As such, we expect the private sector to play a pivotal role in healthcare expansion in Saudi Arabia over the long term, principally through private health insurance schemes.
...The largest pharmaceutical market in the Arabian Peninsula (over half of the total), with steady growth projected over the forecast period. Prescription drug market dominates the market, supported by increasing uptake of private healthcare services and the emergence of a sizeable medical tourism sector. ...The largest pharmaceutical market in the Arabian Peninsula (over half of the total), with steady growth projected over the forecast period. Prescription drug market dominates the market, supported by increasing uptake of private healthcare services and the emergence of a sizeable medical tourism sector. Rising government investment in the local drug industry. ...